← All trials
NCT04913779
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2021
- Primary completion
- Nov 30, 2021
- Completion date
- Dec 31, 2021
- First posted
- Jun 4, 2021
- Last posted
- Sep 17, 2021
- Enrollment
- 200
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Administracion Nacional de Laboratorios e Institutos de Salud Dr. Carlos G. MalbranLead sponsor
- Administracion Nacional de Laboratorios e Institutos de Salud Dr. Carlos G. MalbranReponsible party - principal investigator
- Government of ArgentinaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.